Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3-year survival update and multi-omics analysis.
Dai J, Xu T, Li L, Fang M, Lin J, Cao J, Bai X, Li C, Wei X, Gu J, Liu Y, Gao X, Xia X, Guo J, Chen Y, Mao L, Si L.
Dai J, et al. Among authors: gu j.
Clin Transl Med. 2025 Jan;15(1):e70169. doi: 10.1002/ctm2.70169.
Clin Transl Med. 2025.
PMID: 39757723
Free PMC article.
Clinical Trial.